March 23, 2015 | Israeli medical equipment company SteadyMed Therapeutics raised $40 million in its initial public offering (IPO) on Nasdaq this week. The company’s flagship product is PatchPump, which is a new method of drug delivery. SteadyMed was founded in 2005 by Yossi Eldar and the Zisapel Family.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments